{"id":129726,"date":"2026-03-15T15:47:07","date_gmt":"2026-03-15T15:47:07","guid":{"rendered":"https:\/\/www.europesays.com\/ee\/129726\/"},"modified":"2026-03-15T15:47:07","modified_gmt":"2026-03-15T15:47:07","slug":"te-surete-koik-ara-tosielustaar-kritiseeris-kirglikult-hollywoodi-vallutanud-ravimit","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ee\/129726\/","title":{"rendered":"\u00abTe surete k\u00f5ik \u00e4ra!\u00bb T\u00f5sielustaar kritiseeris kirglikult Hollywoodi vallutanud ravimit"},"content":{"rendered":"<p>\u00abIga t\u0161ikk, keda ma tean, on Ozempicu peal. Inimesed, kes ei vaja Ozempicut!\u00bb teatas 26-aastane USA sisulooja t\u00f5redalt oma TikToki videos, kus ta tegi maha k\u00f5iki neid, kes kaalulangetuse soodustamiseks Ozempicut v\u00f5i sellelaadseid ravimeid kasutavad, kuid tegelikult seda ei vaja.<\/p>\n<p>USA tuntud sisulooja Brianna LaPaglia, kellel on ainu\u00fcksi TikTokis \u00fcle 2,4 miljoni j\u00e4lgija, avaldas, mida tema arvab viimastel aastatel Hollywoodi vallutanud kaalulangetusravimitest.<\/p>\n","protected":false},"excerpt":{"rendered":"\u00abIga t\u0161ikk, keda ma tean, on Ozempicu peal. Inimesed, kes ei vaja Ozempicut!\u00bb teatas 26-aastane USA sisulooja t\u00f5redalt&hellip;\n","protected":false},"author":2,"featured_media":129727,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[80],"tags":[26,27,59185,37,33,35,34,36,31,32,21,59187,19706,3404,3405,59190,59191,28,29,95,19,3401,25,11663,59188,59186,59189,23,24,22,20,30,92,93,94],"class_list":["post-129726","post","type-post","status-publish","format-standard","has-post-thumbnail","category-maailm","tag-breaking-news","tag-breakingnews","tag-brianna-lapaglia","tag-ee","tag-eesti","tag-eesti-keel","tag-estonia","tag-estonian","tag-featured-news","tag-featurednews","tag-headlines","tag-hollywoodi-kaalulangetustrend","tag-hollywoodi-staarid","tag-kaalulangetusravimid","tag-kaalulangus","tag-kaaluprobleemid","tag-korvaltoimed","tag-latest-news","tag-latestnews","tag-maailm","tag-news","tag-ozempic","tag-populaarseimad-lood","tag-semaglutiid","tag-soomishaire","tag-tiktok-sisulooja","tag-toitumishaired","tag-top-stories","tag-topstories","tag-uldised-uudised","tag-uudised","tag-viimased-uudised","tag-world","tag-world-news","tag-worldnews"],"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/129726","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/comments?post=129726"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/posts\/129726\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media\/129727"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/media?parent=129726"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/categories?post=129726"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ee\/wp-json\/wp\/v2\/tags?post=129726"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}